XYL-4001

XYL-4001, formerly known as PSYLO-4001, is a non-hallucinogenic serotonin 5-HT 2A receptor agonist and psychoplastogen which is under development for the treatment of depressive disorders such as major depressive disorder.

Uses your system voice; voice and rate in settings.

≈ 1 min read

Cite, export and learn8 citation formats · 8 exports · lesson and quiz

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

XYL-4001, formerly known as PSYLO-4001, is a non-hallucinogenic serotonin 5-HT 2A receptor agonist and psychoplastogen which is under development for the treatment of depressive disorders such as major depressive disorder. Its route of administration is unspecified. The drug is being developed by Xylo Bio (formerly known as Psylo).

As of January 2025, it is in the preclinical research stage of development. Its chemical structure does not yet appear to have been disclosed.

See also

List of investigational hallucinogens and entactogens List of investigational antidepressants Non-hallucinogenic 5-HT 2A receptor agonist

Pipeline - Psylo

Text derived from https://en.wikipedia.org/w/index.php?oldid=1372054046 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot enwiki-001372054046 · captured 2026-08-30 · ledger · version history

Cite this page as: encyclopegia.org, “XYL-4001”, snapshot enwiki-001372054046. https://encyclopegia.org/a/xyl-4001

Sources cited in this revision

3 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.